Investor Overview

Pardes is a clinical-stage biopharmaceutical company created by and for this moment to solve pandemic-sized problems, starting with COVID-19. We are applying modern reversible-covalent chemistry as a starting point to develop novel drugs while reimagining the patient journey to access these medicines.

Stock
Quote

Webcasts

06/09/2022
at 11:30 AM EDT
03/09/2022
at 11:10 AM PST
02/15/2022
at 3:00 PM PST

Financial Information

Document Date Description Form View

Report of unscheduled material events or corporate event

8-K View HTML EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT

Form of prospectus reflecting facts events constituting substantive change from last form

424B3 View HTML

Amendment to a previously filed 4

4/A View HTML

Contact
IR

Send us an investor-related question using the form below.